Lapatinib Ditosylate from Mexico
Lapatinib ditosylate is a dual tyrosine kinase inhibitor for HER2-positive breast cancer. The core quinazoline structure (aromatic heterocyclic with nitrogen) places it under HTS 2933.99.75.00 as a drug.
Duty Rate — Mexico → United States
16.5%
Rate breakdown
9903.05.5510%Section 301 (forced labor) — additional 10% ad valorem on products of Mexico
Import Tips
• Declare as 'Lapatinib ditosylate monohydrate' if hydrated form per CoA
• Include bioequivalence data if generic import competing with originator